The PREMIER project, a public-private European consortium of research organizations (like Radboud University) and international pharmaceutical companies, has launched a new database to support the environmental risk assessment (ERA) of human pharmaceuticals. The data is publicly accessible, free of charge. The database was built with key user requirements in mind.
New European Database Launched for Environmental Risk Assessment of Human Pharmaceuticals
The PREMIER project, a European consortium including research organizations and pharmaceutical companies, has launched a new database for environmental risk assessment of human pharmaceuticals. This initiative is publicly accessible and aims to address key user requirements. The development of such databases could influence Iran's approach to environmental health and pharmaceutical regulations.
👥 Key Players
📰 What Happened
The PREMIER project has launched a new database aimed at supporting the environmental risk assessment of human pharmaceuticals, making the data publicly accessible and free of charge.
- The database is designed with key user requirements in mind.
- It involves collaboration between research organizations and international pharmaceutical companies.
💡 Why It Matters
📚 Background
Environmental risk assessments are crucial for ensuring that pharmaceuticals do not harm ecosystems or public health. This database aims to provide essential data for such assessments.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%